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Introduction
Diabetic wounds are a severe complication of diabetes that aggravates the patient's condition, and affects a dramatically increasing population. [1] In view of the specific pathophysiological abnormalities of the wound environment including prolonged inflammation, vascular problems, inhibited re-epithelialization, a major failure has been seen with single treatment or FDA approved therapy devices. [2] Therefore, a combined therapeutic approach using advanced technologies that alleviates the deleterious pathological factors is of great interest. There is a great promise for stem cell-based treatment for diabetic wounds that has been reported over the past decade. [3] However, the hostile wound environment minimizes the retention and survival of stem cells, which significantly limits the clinical translation of stem cell therapy. To maintain and protect the stem cells that have been delivered onto the harsh diabetic environment, hydrogel systems have been explored to improve the engraftment of transplanted stem cells for diabetic wound repair. [4] Among them, in situ formed injectable hydrogel system has attracted much attention for wound healing application in recent years. [5] [6] [7] The injectable hydrogel can be easily applied on any irregular shape during hydrogel formation without using the complex mould, [8] [9] [10] and possess the advantages of easy administration, efficient cell encapsulation, minimal invasion, and enhanced patient compliance, [11] making them attractive for various biomedical applications. The components of injectable hydrogels range from natural (e.g.
hyaluronic acid, chitosan, alginate, collagen, gelatin) to synthetic (e.g. poly(ethylene glycol), polyacrylamide, Poly(Lactide-co-Glycolide)) materials. [4] Naturally derived hydrogels have been frequently used in tissue engineering, as the components have the same or similar properties to the natural extracellular matrix (ECM). [12] However, these naturally derived biomaterials always show large heterogeneity in structure, poor stability and mechanical performance as well as relatively high cost. [13] Synthetic hydrogels are appealing for tissue engineering and regeneration as their properties are tunable, reproducible, and much easier to pre-design in order to meet numerous of specific requirements. [12] Although there have been various synthetic injectable hydrogels reported for wound healing application, a majority of the reported hydrogels suffer from potential toxicity, less biological cues and unsuitable mechanical properties, etc. which prevent the successful clinical translation of synthetic hydrogels. [14, 15] Therefore, a well-designed in situ formed injectable hydrogel system that combines a well-constructed synthetic polymer with a properly selected naturally derived biopolymer could be an appropriate consideration to create improved materials to achieve an effective healing process.
Among numerous synthetic biomaterials, poly(ethylene glycol) (PEG) and its derivatives have been extensively used for fabrication of biocompatible hydrogels for cell culture scaffolds [16] and tissue engineering. [17] However, the conventional linear and/or multi-armed star PEG (4-armed or 8-armed) based materials are suffering from their low functional group density, which largely restricts their reaction efficiency. One solution is to construct PEG materials with highly branched structures.
As one of the classical approaches to synthesize branched polymers, 'Strathclyde route' is using free radical polymerization of mono-vinyl monomers with a small amount of divinyl crosslinkers. [18] However, the polymers produced by such an approach still possess limited pendent vinyl groups, which make them not ideal candidates as the crosslinkers to form injectable hydrogels. To overcome this drawback, Wang et al. proposed a kinetically controlled strategy to polymerize the multi-vinyl monomers. [19] [20] [21] [22] [23] [24] PEG based hyperbranched polymers with high branching degree and pendent vinyl density were successfully achieved. [25] [26] [27] [28] The high content of pendent vinyl groups endows them the ability to generate in situ injectable hydrogel systems rapidly. However, there is still one significant limitation on the previous studies which used atom transfer radical polymerization (ATRP) requiring potential toxic copper catalysts.
To address this issue, reversible addition fragmentation chain transfer (RAFT) polymerization has been used to synthesize PEG polymers without using toxic metal catalysts. [6, 29] While, the most significant challenges in RAFT polymerization are the complicated synthesis procedure for RAFT agents, which needs to use noxious and toxic organic reagents (carbon disulfide or iodine), and the subsequent time-consuming reaction and purification steps. [ The efficacy of the HP-PEG/HA-SH/ADSC system for the treatment of diabetic wound healing was assessed on a humanized excisional diabetic wound model in rats.
Materials and Methods

Differentiation test for ADSCs encapsulated in the HP-PEG1/HA-SH hydrogel
Immunofluorescence for Oct4, Sox2, and Nanog for ADSCs was carried out to detect the undifferentiated status. HP-PEG/HA-SH/ADSCs was first fixed with 4% paraformaldehyde, and then reacted with antibodies against Oct4, Sox2, and Nanog. After washed with PBS/Triton X-100, the hydrogel reacted with corresponding secondary antibodies, and counterstained with DAPI.
Immunofluorescence was observed with a fluorescence microscope.
For in vitro differentiation assessment, ADSCs were induced by relative induction media and media without growth factors, separately.
Adipogenic induction medium: Preadipocyte basal medium-2 supplemented with 16.6% FBS, 50
μg mL -1 ascorbate-2 phosphate, 10 -7 M dexamethasone, 50 μM indomethacin, 0.45 mM 3-isobutyl-1-methyl-xanthine and 10 μg mL -1 insulin.
Chondrogenic induction medium: add ITS + (Gibco-BRL) and 10 ng mL -1 TGF-1 (Preprotech, Rocky Hill, NJ) into MSC differentiation medium -chondrogenic (PT3925).
Osteogenic induction medium: MSC differentiation medium-osteogenic (PT3924) supplemented with 16.6% FBS, 50 μg mL -1 ascorbate-2 phosphate), 10 -8 M dexamethasone and 10 mM -glycerophosphate.
After separate induction, ADSCs were stained by oil red O, Alizarin red, and safranin-O to detect the morphology.
Growth factors secretion of ADSCs encapsulated in the HP-PEG1/HA-SH hydrogel
Conditioned media was collected from ADSCs seeded in the hydrogels or plated in wells after 1, 4, and 7 days incubation. Angiogenic protein levels of PIGF, VEGF, and TGF-β were quantified using multi-plex ELISA system (Sigma). Wounds were examined every other day and hydrogels were harvested at 3, 7, 11, 14, and 21 days post-wounding. Residual hydrogel was taken and weighted (4 samples for each condition).
Animals
Diabetic animal model
In order to generate diabetic animals, STZ was used to chemically induce healthy SD rats to develop type 1 diabetes via cauda vein injection (45 mg kg -1 of STZ dissolved in a 0.1 M sodium citrate buffer). Diabetes was verified by serum glucose levels after the injection. Serum glucose level > 16.7 mmol L -1 for at least 4 weeks was defined as successfully developed diabetic rat model. The serum glucose levels were tested pre-and post-injection, and every 7 days during the experiments with a blood glucose meter (OneTouch Ultra ® Blood Glucose Monitoring System).
Humanized diabetic wound model and treatment groups
To better mimic the human wound healing process, a splinted excisional wound model was utilized to prevent wound contraction and allow wound healing through re-epithelialization and granulation tissue formation. Briefly, after full thickness excisional skin wound of 1.1 cm diameter circle was created on the dorsum, wound was circumscribed by silicone rings sutured onto the skin surface surrounding the excision area with 5-0 nylon. Four wounds were generated on each animal. Animals Digital images were taken at scheduled time points (days 0, 11, 21 post-procedure). The wound area was measured by two blinded evaluators via Image J software (n = 8 wounds for each condition).
Wound closure rate (%) was defined as: (origin wound area -residual wound area at day 'X') / origin wound area × 100%.
Histological analysis
At scheduled time points, wound tissues were excised and immediately fixed in 4%
formaldehyde/PBS solution overnight. Samples were then dehydrated with a graded series of ethanol and embedded in paraffin. Tissues were then sectioned into slices with a thickness of 5 μm and stained by hematoxylin and eosin (H&E, Sigma-Aldrich), and Masson's trichrome (Sigma-Aldrich) and visualized by an optical microscope.
Masson's trichrome stained sections were utilized to measure the newly formed dermis thickness, using the Image J software (n = 8 wounds for each condition) with a minimum of 6 measurements per sample. Percentage of neo-dermis thickness (%) was calculated as (neo-dermis thickness / the surrounded normal dermis thickness) × 100%.
Immunohistochemistry and immunofluorescence
For the immunohistochemical staining, 5 μm thickness paraffin sections were deparaffinized, washed three times in PBS for 5 min. Then the sections were blocked with 5% serum for 30 min. 
Statistical analysis
All values are expressed as mean ± standard deviation (SD). Statistical differences between two groups were determined using the student's unpaired t test. A p value < 0.05 was considered statistically significant.
Results and discussion
In order to explore the optimal reaction condition of in situ RAFT polymerization, six batches of polymerizations were carried out as shown in Supplementary table 1.
Firstly, two reactions as controls were carried out without the use of 2,2'-Azobis(2-methylpropionitrile) (AIBN) (Entry 1) or DS (Entry 2), respectively.
Entry 1 showed no sign for the occurrence of polymerization as no polymer peak was detected by GPC even after 24 h, while Entry 2 formed a crosslinked network rapidly within 15 min indicating an uncontrollable reaction behaviour. Then, two ratios (1:2 and 1:1.4) of DS to AIBN as well as different reaction temperatures were evaluated for the in situ RAFT polymerization of PEGDA (Entry 3-6). As shown in Figure   2A -2D, the polymer mixtures are still soluble even when the monomer conversion was up to 60% for all the four systems, demonstrating the critical roles of DS in the reaction to in situ form the RAFT agents. Such high monomer conversion is unexpected given the Flory-Stockmayer theory predicted that such system will be gelled at low monomer conversion. Similar results were also reported in our previous work [6, 19, [21] [22] [23] and attributed to the kinetic control over the chain growth, inter-/intra-molecular crosslinking. Moreover, polymerization process shows a two-stage growth behaviour. At the early stage (monomer conversion less than 40%),
Mw increased with monomer conversion in a linear manner and the GPC traces ( Figure S1 ) showed single peaks with a low PDI. While in the later stage, the Mw increased rapidly and GPC peaks showed a multiple peaks with a high PDI, indicating the occurrence of the intermolecular crosslinking, combination of the polymer chains in the reaction system. [22, 23] The reaction kinetic was studied by varying the AIBN/DS ratio and temperature. As shown in Figure 2E , more AIBN feeding results in a much faster polymerization rate and a higher PDI at the same conversion. Thus, the feeding ratio of 1:1.4 (molar ratio of DS: I) was selected to delay the later stage of polymerization compared with the feeding ratio of 1:2. Similarly, the optimized reaction temperature is selected at 70 o C.
The samples taken from Entry 4 were purified, and the polymer structure was Figure S4 ). Based on the comparison of the amount of pendent unit with the amount of entire monomer repeating units, the branch ratios were calculated, which showed values of approximately 32% and 45% ( Figure   S3 ), respectively. We can also observe from the 1 H-NMR spectrum of a purified HP-PEG1 polymer that the peaks of DS and AIBN moieties can be found within the polymer chains, which reveals that the polymerization follows the proposed in situ RAFT polymerization ( Figure 2F ).
Injectable HP-PEG/HA-SH hydrogels
PEG/HA hydrogels have been studied in the field of tissue engineering for years. Shea To reveal the mechanical properties of HP-PEG/HA-SH hydrogels, rheological measurements were performed during the gelation process sequentially using time and frequency sweep ( Figure 3B and Figure S5) . Typically, at the concentration of 5%, HP-PEG1/HA-SH exhibit approximate 136 Pa of storage modulus which is within the range of storage modulus of soft tissue ( Figure 3C ). Both hydrogels showed low frequency dependence ( Figure S6 and Figure S7 ) for all concentrations, demonstrating that the hydrogels are highly elastic. [7] Proper mechanical properties can support the encapsulated cells with a favorable environment as well as no extra burden to the host tissues.
To study the hydrogel swelling and degradation properties in vitro, the hydrogel samples (5% (w/v)) were incubated in PBS buffer at 37 o C. After the hydrogels reached their equilibrium swelling levels within 1 day, their wet weight remained almost constant for 4 days. The hydrogels then showed slight swelling within 40 days (1.9-time of original weight) ( Figure 3D ). The hydrogels underwent remarkable swelling and became shapeless after 40 days. The hydrogel structure started to break and finally disappeared after it reached the maximum water retention ability. Thus, we successfully obtained a non-swelling hydrogel system, which avoids the limitations of weak mechanical toughness caused by swelling. This kind of non-swelling profile, in a relatively long time period, will result in less medical complications caused by high hydrogel swelling ratios, which is a desirable advantage of hydrogels being applied onto wound sites.
To investigate the porosity and morphology of the hydrogel, SEM were used to capture the microstructure. The HP-PEG/HA-SH hydrogels show a microporous sponge-like structure with the pore size ranging from 5 to 20 μm ( Figure S8 ).
We also tested the antifouling property of our hydrogel systems, because the PEG derivatives have been proved to be an antifouling biomedical material due to its biocompatibility and hydrophilicity. The HP-PEG1/HA-SH hydrogel exhibits a relatively lower amount of protein adsorption than the collagen/chitosan hydrogel and HP-PEG1 hydrogel (formed by UV curing) from 2 to 24 h incubation period with FBS solution ( Figure 3E ). The well-maintained antifouling property endows the hydrogel with the ability to mitigate the effects of the foreign body response after implantation.
In view of the suitable mechanical stability, the injectable profile, and the non-swelling and antifouling properties, we believe this hydrogel system to have chemical advantages and potential satisfaction for both medical specialists and patients,
providing it with great superiority as an alternative biomaterial for wound healing.
Biocompatibility of HP-PEG/HA-SH hydrogels
To determine the biocompatibility of HP-PEG polymers and HP-PEG/HA-SH hydrogels, 3T3 and ADSCs were used for in vitro cell viability tests by alamarBlue assay. Both cell lines showed high cell viability when cocultured with different polymer concentrations ( Figure S9 ). The cytotoxicity test for the hydrogels were conducted by seeding the cells into the HP-PEG/HA-SH hydrogels and evaluated by alamarBlue assay. Both hydrogels exhibited high cell viability for both cell lines ( Figure S10 ), indicating that this in situ hydrogel system did not show toxicity on the cells. We also performed in vivo biosafety and degradation test of both hydrogels. After implantation, no signs of infection, inflammation or rejection were detected. The hydrogels exhibited minimal swelling and a slow degradation rate within 21 days ( Figure S11 ). In the current study, we selected HP-PEG1/HA-SH hydrogel with 5% angiogenesis and re-epithelialization. [3, 45] However, the maintenance of cell viability and stemness is an urgent issue to be solved under the hostile environment of DFUs. We then further detected the ADSCs' behaviors (self-renewal and secretion ability) in this hydrogel system. The expression of Oct4, Sox2, and Nanog, which are key regulators for maintenance of self-renewal and multipotency of ADSCs, [7, 46] was verified by immunological staining method ( Figure 4A ). Most of the ADSCs are showing positively stained Oct4, Sox2, or Nanog after 2, 5, and 7 days seeding in the hydrogel.
We also assessed the differentiation status of the encapsulated ADSCs with or without specific induction media. After induction, ADSCs are directed to differentiate into adipogenic, osteogenic, and chondrogenic lineages, verified by the staining of oil red O, safranin-O, and alizarin red staining, respectively ( Figure 4B ), while the ADSCs, without induction, showed no sign of differentiation. These data demonstrated that ADSCs maintained their stemness well even in the hydrogel. The protein level of pro-angiogenic growth factors was detected on conditioned media from hydrogel and plated culture conditions. It can be noted that the protein levels of PIGF, VEGF, and TGF-β were increased from day 1 to day 7 in both conditioned media ( Figure 4C, D, and E). PIGF expression was found to be significantly increased at day 7 in hydrogel cultured ADSCs compared to those cultured in standard conditions. VEGF and TGF-β expression was found to significantly increased at day 1 and day 4. The ability of maintaining the multi-potency and secretion capacity of wound healing associated growth factors of these encapsulated ADSCs in the HP-PEG-based hydrogel exhibits potential therapeutic value in regenerative medicine, indicating the possibility of the combination therapy in promoting wound healing.
HP-PEG/HA-SH/ADSCs promotes humanized diabetic wound healing process
To test the efficiency of the injectable HP-PEG/HA-SH hydrogel in promoting wound healing, a humanized excisional wound model, which can better mimic human skin wound repair mechanisms [47] , was developed in the Streptozotocin induced diabetic SD rats. To validate our hypothesis that the HP-PEG/HA-SH/ADSCs system can accelerate diabetic wound healing, no-treatment (blank), and treatment with The prolonged inflammation, reduced vascular formation, and non-migratory epidermis in diabetic wound beds are considered to be essential factors in impaired and delayed diabetic wound healing. To further study the mechanism behind the accelerated healing, we performed immunohistochemistry or immunofluorescence assays for the wound tissues. Inflammatory factors (CD11b, TNF α, IL-1β) expression were significantly inhibited at days 11 and 21 in HP-PEG/HA-SH/ADSCs hydrogel treated wounds, indicating the prolonged inflammatory phase is reversed ( Figure 6A , Figure   S12 and Figure 7 ). To study the angiogenesis behaviours during the healing, protein expression of key factors related to vascular development (VEGF, CD31, and α-SMA)
were detected. The number of CD31 and α-SMA positive stained vessels of each wound was counted ( Figure 6B and Figure 6C ), respectively. CD31 + and α-SMA + vessel densities were significantly higher in HP-PEG/HA-SH/ADSCs hydrogel treated wounds at day 21. VEGF expression also indicated a higher level in HP-PEG/HA-SH/ADSCs hydrogel treated wounds demonstrating a positive effect for angiogenesis ( Figure 6D ). Enhanced re-epithelialization rate was evidenced by the gap-junctional connections of keratinocytes layers ( Figure 6E and Figure S13 ) at day 21. There are also significant differences between cell only and hydrogel/cell treated wounds, such as increased neodermis thickness, inhibited inflammatory factors expression, enhanced CD31 and VEGF expression and re-epithelialization at 21 days from Figure 6 . Based on the histological assays, the HP-PEG/HA-SH/ADSCs system presented significant advantages for diabetic wound healing, including prevention of persistent inflammation, promotion of vasculogenesis, and re-epithelialization compared to the wounds without treatment.
Conclusion
In this report, we have described the development of an new injectable hydrogel platform as a stem cell delivery and retention system. The in situ RAFT polymerization of PEGDA using DS as a RAFT agent precursor endows the resultant hyperbranched PEG polymers good biocompatibility and abundant pendent acrylate groups, which can be utilized to form an injectable hydrogel with a rapid gelation rate and a tunable mechanical property. The HP-PEG/HA-SH hydrogels also demonstrated non-swelling and antifouling properties, as well as well-retained stem cell properties in vitro. Furthermore, this versatile hydrogel system encapsulated with ADSCs exhibited an accelerated diabetic wound healing process through inhibiting inflammation, promoting angiogenesis and re-epithelialization.
